Arielle Smith, the President of Life Science at Event Cadence, discusses the changes in the event technology landscape and the expectations of pharmaceutical companies and attendees for a hybrid approach, including participation in person and virtually. There is an increased demand for insight capturing and analytics to measure the return on investment in conferences and the time attendees spend there. The platform includes scheduling, appointment management, and lead generation with tools to encourage networking and interaction to enhance the event experience.  

Arielle explains, "Medical conferences are held all over the world, as you know, and there's not always going to be a time where you can physically put boots on the ground and travel for them. So we're seeing a lot more of a hot tier point, a hybrid model approach to it where, let's say, the majority of the team will be in a meeting room face to face with some of their HCPs, but then even that HCP might decide to dial in their counterpart. Or if a pharmaceutical client is not able to participate in person for many different reasons, we're looping them in from a virtual perspective as well. And our platform can help coordinate all of that."

"So there's a lot of talk in the industry about insight capturing and gathering and exactly how that can be done but how best to make it actionable. Many great platforms are spinning up recently that are meant for capturing recordings or recording a conversation like the one you and I are having now, but then using AI to transcribe it all. A lot of our accounts are playing with technology like that, and then our platform is being used to set those conversations up." 

#EventCadence #MedicalConferences #ConferenceManagement #HybridConferences

eventcadence.com

Download the transcript here